Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC

被引：27

作者：

Herbaux, Charles ^{[1
]}

Gauthier, Jordan ^{[2
]}

Brice, Pauline ^{[3
]}

Fornecker, Luc ^{[4
]}

Bouabdallah, Krimo ^{[5
]}

Manson, Guillaume ^{[6
]}

Ghesquieres, Herve ^{[7
]}

Thiebaut-Bertrand, Anne ^{[8
]}

Demarquette, Helene ^{[1
]}

Boyle, Eileen ^{[1
]}

Ysebaert, Loic ^{[9
]}

Houot, Roch ^{[10
]}

Yakoub-Agha, Ibrahim ^{[11
]}

Morschhauser, Franck ^{[12
]}

机构：

[1] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France

[2] CHRU Lille, Hop Huriez, F-59037 Lille, France

[3] Hop St Louis, AP HP, Hematol, Paris, France

[4] Hop Hautepierre, Oncol & Hematol, Strasbourg, France

[5] CHU Bordeaux, Bordeaux, France

[6] CHU Rennes, Rennes, France

[7] Ctr Leon Berard, Dept Haematol, F-69373 Lyon, France

[8] CHU Grenoble, F-38043 Grenoble, France

[9] CHU Purpan, Toulouse, France

[10] CHU Rennes, INSERM, U917, Rennes, France

[11] CHU Lille, Hematol, F-59037 Lille, France

[12] Univ Lille 2, Ctr Hosp Univ, Hematol, Lille, France

来源：

关键词：

D O I：

10.1182/blood.V126.23.3979.3979

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3